Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Philips new CEO is overhauling company culture and adding a role to the C-suite

The CEO can't afford anymore disasters as he pushes deeper into AI-assisted medicine.

Fortune

How cold should a refrigerator be? Here’s what the experts say

Struggling to know how cool to keep your refrigerator? Want to know what to do if there's a power outage? We've got the top advice from appliance experts.

Tom’s Guide

Flu shots have changed this year — here's why

Unlike past flu shots, flu vaccines for the 2024-2025 season don't contain the "Yamagata lineage" of influenza viruses because evidence suggests that type of flu no longer exists.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

Dilated cardiomyopathy in dogs: Everything you need to know

Dilated cardiomyopathy in dogs is a common heart disease – our vet tells you everything you need to know about this serious condition.

PetsRadar

California Bans 6 Harmful Dyes In School Food Linked To Behavioral Issues

The new law, part of the California School Food Safety Act, bans the use of six artificial dyes: Red 40, Yellow 5, Yellow 6, Blue 1, Blue 2, and Green 3, in food and drinks served at public schools.

Medical Daily

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

Reason

Stocks Settle Lower on Weakness in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.53%. Stocks on Friday settled mixed, with the Dow Jones Industrials climbing...

Barchart

Read news from The Economist, FT, and more,
with one subscription

Inflation Report Sparks Mixed Market Reaction

The S&P 500 Index ($SPX ) (SPY ) today is down by +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.36%. Stocks today are mixed, with the Dow Jones Industrials climbing to...

Barchart

New schizophrenia drug ‘could change the lives of millions of people’

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

The Independent UK

Dow Jones Climbs to New Record Highs, While the Nasdaq Slides

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.30%. Stocks today are mixed, with the Dow Jones Industrials climbing to...

Barchart

Stocks See Support as Bond Yields Fall on Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.11%. Stocks today are mixed, with the Dow Jones Industrials climbing to...

Barchart

Stocks See Support from Fed-Friendly US Economic Reports

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.03%. Stocks today are mildly higher, with the Dow Jones Industrials climbing...

Barchart

Is This Penny Stock With 55% Upside A Buy Now?

This biotech company currently has an approved product on the market. However, there is more to the story than meets the eye.

Barchart

Cobenfy Gets FDA Approval: New Drug Offers Novel Treatment Mechanism For Schizophrenia

The new drug Cobenfy promises to revolutionize treatment for schizophrenia with its novel mechanism, the first of its kind in decades.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

FDA issues recall notices for pet foods

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

TechRadar

Molekule Air Pro review: an air purifier that filters well, but it’s very pricey

The Molekule Air Pro is the high-priced but undeniably high-quality air purifier I never knew I needed.

LiveScience

New self-swab HPV test is an alternative to Pap smears. Here's how it works.

There's a new way to screen for high-risk HPV, a viral infection that can lead to cervical cancer. This alternative method of collecting samples for cervical cancer screening doesn't require a speculum.

Barchart

Is Eli Lilly Stock Still a Buy Near All-Time Highs?

With a robust performance, strategic expansions, and strong analyst endorsements, Eli Lilly appears poised for continued growth, making it a compelling investment opportunity.

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

Does Tracking Lead To Better Sleep? A Long-Term Test With the Samsung Galaxy Ring

Does tracking sleep lead to better rest? We take a long, long sleep with Samsung’s Galaxy Ring to determine what works and what doesn't — and what the science tells us.

LiveScience

At-home flu vaccine approved by FDA — what to know

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.

Salon

Lactaid Milk is being recalled

HP Hood and the FDA announced a voluntary recall of 96-ounce containers of Lactaid Milk on Sept. 20

The Independent UK

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

StockNews.com

3 Biotech Stocks That Could Deliver Big Gains

The biotech industry is poised for significant growth, fueled by advanced technologies, the increased commercialization of new therapeutics, and increased R&D spending on treatments for new and rare diseases. Hence, investors should consider strong biotech stocks such as Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which could deliver big…

TechRadar

Evaluating embedded vulnerabilities and cybersecurity risks in procurement

Many companies assume the software they purchase is secure. Recent high-profile software supply chain breaches have proven otherwise.

International Business Times

Unnecessary Legislation Could Clog The Drug Development Pipeline

The Medication Affordability and Patent Integrity Act would add additional mountains of redundant paperwork requirements for biotechs to navigate.

1 … 76 77 78 79

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Food and Drug Administration

the Centers for Disease Control and Prevention

209 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.